These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recent progress in the development of coumarin derivatives as potent anti-HIV agents. Yu D; Suzuki M; Xie L; Morris-Natschke SL; Lee KH Med Res Rev; 2003 May; 23(3):322-45. PubMed ID: 12647313 [TBL] [Abstract][Full Text] [Related]
3. Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity. Esposito F; Ambrosio FA; Maleddu R; Costa G; Rocca R; Maccioni E; Catalano R; Romeo I; Eleftheriou P; Karia DC; Tsirides P; Godvani N; Pandya H; Corona A; Alcaro S; Artese A; Geronikaki A; Tramontano E Eur J Med Chem; 2019 Nov; 182():111617. PubMed ID: 31442684 [TBL] [Abstract][Full Text] [Related]
4. Coumarins as inhibitors of HIV reverse transcriptase. Kostova I Curr HIV Res; 2006 Jul; 4(3):347-63. PubMed ID: 16842086 [TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, Molecular Modeling and Anti-HIV Assay of Novel Quinazolinone Incorporated Coumarin Derivatives. Safakish M; Hajimahdi Z; Aghasadeghi MR; Vahabpour R; Zarghi A Curr HIV Res; 2020; 18(1):41-51. PubMed ID: 31820700 [TBL] [Abstract][Full Text] [Related]
6. Rational design and Structure-Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase. Zhu M; Ma L; Wen J; Dong B; Wang Y; Wang Z; Zhou J; Zhang G; Wang J; Guo Y; Liang C; Cen S; Wang Y Eur J Med Chem; 2020 Jan; 186():111900. PubMed ID: 31771827 [TBL] [Abstract][Full Text] [Related]
7. Recent Progress in Synthesis, POM Analyses and SAR of Coumarin-Hybrids as Potential Anti-HIV Agents-A Mini Review. Suleiman M; Almalki FA; Ben Hadda T; Kawsar SMA; Chander S; Murugesan S; Bhat AR; Bogoyavlenskiy A; Jamalis J Pharmaceuticals (Basel); 2023 Oct; 16(11):. PubMed ID: 38004404 [TBL] [Abstract][Full Text] [Related]
8. Quinolone derivatives: Potential anti-HIV agent-development and application. Wang R; Xu K; Shi W Arch Pharm (Weinheim); 2019 Sep; 352(9):e1900045. PubMed ID: 31274223 [TBL] [Abstract][Full Text] [Related]
9. Structural analogues of the calanolide anti-HIV agents. Modification of the trans-10,11-dimethyldihydropyran-12-ol ring (ring C). Zembower DE; Liao S; Flavin MT; Xu ZQ; Stup TL; Buckheit RW; Khilevich A; Mar AA; Sheinkman AK J Med Chem; 1997 Mar; 40(6):1005-17. PubMed ID: 9083491 [TBL] [Abstract][Full Text] [Related]
10. In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI. Xu ZQ; Buckheit RW; Stup TL; Flavin MT; Khilevich A; Rizzo JD; Lin L; Zembower DE Bioorg Med Chem Lett; 1998 Aug; 8(16):2179-84. PubMed ID: 9873509 [TBL] [Abstract][Full Text] [Related]
11. Anti-breast Cancer Potential of Natural and Synthetic Coumarin Derivatives. Song F; Huo X; Guo Z Curr Top Med Chem; 2021; 21(18):1692-1709. PubMed ID: 33655862 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of quinoxaline compounds as anti-HIV agents targeting reverse transcriptase enzyme. Fabian L; Taverna Porro M; Gómez N; Salvatori M; Turk G; Estrin D; Moglioni A Eur J Med Chem; 2020 Feb; 188():111987. PubMed ID: 31893549 [TBL] [Abstract][Full Text] [Related]
13. Anti-AIDS agents. 37. Synthesis and structure-activity relationships of (3'R,4'R)-(+)-cis-khellactone derivatives as novel potent anti-HIV agents. Xie L; Takeuchi Y; Cosentino LM; Lee KH J Med Chem; 1999 Jul; 42(14):2662-72. PubMed ID: 10411486 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic Potential of Indole Derivatives as Anti-HIV Agents: A Mini-review. Chen Q; Wu C; Zhu J; Li E; Xu Z Curr Top Med Chem; 2022; 22(12):993-1008. PubMed ID: 34636313 [TBL] [Abstract][Full Text] [Related]
15. Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide. Buckheit RW; White EL; Fliakas-Boltz V; Russell J; Stup TL; Kinjerski TL; Osterling MC; Weigand A; Bader JP Antimicrob Agents Chemother; 1999 Aug; 43(8):1827-34. PubMed ID: 10428899 [TBL] [Abstract][Full Text] [Related]
16. 1,2,3-Triazole hybrids with anti-HIV-1 activity. Feng LS; Zheng MJ; Zhao F; Liu D Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000163. PubMed ID: 32960467 [TBL] [Abstract][Full Text] [Related]
17. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. Kashman Y; Gustafson KR; Fuller RW; Cardellina JH; McMahon JB; Currens MJ; Buckheit RW; Hughes SH; Cragg GM; Boyd MR J Med Chem; 1992 Jul; 35(15):2735-43. PubMed ID: 1379639 [TBL] [Abstract][Full Text] [Related]
18. Structure-Activity Relationships of Synthetic Coumarins as HIV-1 Inhibitors. Kostova I; Raleva S; Genova P; Argirova R Bioinorg Chem Appl; 2006; 2006():68274. PubMed ID: 17497014 [TBL] [Abstract][Full Text] [Related]
19. [Progress in the new nonnucleoside anti-HIV reverse transcriptase inhibitor-DCK]. Guo HF; Xie L Yao Xue Xue Bao; 2008 Oct; 43(10):997-1002. PubMed ID: 19127862 [TBL] [Abstract][Full Text] [Related]
20. Chemical constituents of Prangos tschiniganica; structure elucidation and absolute configuration of coumarin and furanocoumarin derivatives with anti-HIV activity. Shikishima Y; Takaishi Y; Honda G; Ito M; Takfda Y; Kodzhimatov OK; Ashurmetov O; Lee KH Chem Pharm Bull (Tokyo); 2001 Jul; 49(7):877-80. PubMed ID: 11456095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]